Janjigian, Y. Y., Van Cutsem, E., Muro, K., Wainberg, Z., Al-Batran, S., Hyung, W. J., . . . Tabernero, J. (2022). MATTERHORN: Phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer. Future oncology (London, England), 18(20), 2465. https://doi.org/10.2217/fon-2022-0093
Citácia podle Chicago (17th ed.)Janjigian, Yelena Y., et al. "MATTERHORN: Phase III Study of Durvalumab Plus FLOT Chemotherapy in Resectable Gastric/gastroesophageal Junction Cancer." Future Oncology (London, England) 18, no. 20 (2022): 2465. https://doi.org/10.2217/fon-2022-0093.
Citácia podľa MLA (8th ed.)Janjigian, Yelena Y., et al. "MATTERHORN: Phase III Study of Durvalumab Plus FLOT Chemotherapy in Resectable Gastric/gastroesophageal Junction Cancer." Future Oncology (London, England), vol. 18, no. 20, 2022, p. 2465, https://doi.org/10.2217/fon-2022-0093.